The Dow is pulling back, but one of its components just posted a historic earnings reaction.
July 20, 2026
The Dow Jones Industrial Average just posted back-to-back negative weeks for the first time since the corrective wave that ended in late March.
And that matters because the Dow is still one of the most important stock market indexes in the world.
When it starts cooling off, we want to know which stocks are holding up, which ones are breaking down, and which names are showing relative strength.
Friday gave us an answer.
Travelers Companies $TRV, one of the largest property and casualty insurers in the world and a member of the Dow, reported a blowout quarter and rallied 9.2% for its best earnings reaction of the 21st century.
As a result, the stock closed at a new all-time high and was the standout reaction on Friday’s Beat Sheet.
*Click the image to enlarge it
Travelers didn’t just beat expectations...
It destroyed them!
The market was looking for $5.41 in earnings per share. Travelers reported $10.04.
That kind of upside surprise is exactly why the stock exploded higher.
Travelers generated $2.2 billion in core income, produced a 24.9% core return on equity, improved its combined ratio to 83.6%, and grew net investment income 14% to $883 million.
The company also returned more than $1.5 billion of capital to shareholders during the quarter, including $1.3 billion of share repurchases.
That's what a high-quality earnings engine looks like.
And the chart agrees.
Travelers carved out a clean bottom in 2022 and 2023, ripped higher in 2024, and then spent the past year and a half digesting those gains in a tight consolidation.
Friday’s reaction changed the character of that pattern.
Price broke out of the range, closed at new all-time highs, and confirmed that buyers remain firmly in control.
This is exactly the type of alignment we look for at the Beat Report.
With very strong technicals, fundamentals, and earnings sentiment, we expect TRV to continue making new all-time highs.
But Friday’s tape wasn't all green...
Intuitive Surgical $ISRG was the exact opposite story.
ISRG reported a top- and bottom-line beat, yet the stock fell 14.5% for its worst earnings reaction since Q2 2022.
The company itself is still growing, but the market didn't care.
And that’s the part we cannot ignore.
Intuitive Surgical has been carving out a large distribution pattern since early 2024.
Then Friday’s earnings reaction pushed the stock decisively below the key $370 level, which had acted as resistance back in 2021 and later flipped into support in 2024.
Now that level has been decisively broken.
So long as ISRG remains below $370, the path of least resistance is decisively lower for the foreseeable future.
This is especially interesting because we just wrote about medical devices in Friday’s Daily Beat.
Medical devices have been among the weakest groups in healthcare, but they're at a key level of interest relative to XLV.
We've been thinking it's time for some intrasector rotation to come into medical devices.
Abbott Labs $ABT, the largest medical device stock in the world, supported that idea with a 10.7% rally after earnings, marking its best earnings reaction of the 21st century.
Then one day later, Intuitive Surgical got crushed.
That's serious bifurcation...
Abbott is being rewarded while Intuitive is being punished.
Same broad industry group. Completely different market response.
And that's why we do this work every day.
At the Beat Report, we're not simply asking whether a company beat estimates.
We're asking a better question: Did the market reward the news?
For Travelers, the answer was a loud yes.
Meanwhile, Intuitive Surgical was a loud no.
And until that changes, we know which side of the tape we would rather be on.
Join the Beat Report today to get our next trade alert, our current watchlist, and access to the stocks we believe have the strongest alignment across technicals, fundamentals, and earnings sentiment.
Thank you for reading,
-The Beat Team
Editor's Note: Grant Hawkridge just walked through his entire Green Light system live: the one number he reads before bed, the three steps behind it, and how it sidestepped the 2022 bear and the COVID drawdown.
If you missed it, the full replay is up now. Watch it here.
